News from atheronova inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 05, 2013, 07:00 ET

AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 15, 2013, 07:00 ET

Atherosclerosis Researcher Dr. Erik Stroes Joins AtheroNova's Clinical Advisory Board

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Sep 19, 2013, 07:00 ET

AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 27, 2013, 08:00 ET

AtheroNova Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 25, 2013, 07:00 ET

AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

May 30, 2013, 08:01 ET

AtheroNova Announces Shipment of Phase 1 Drug Product

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

May 09, 2013, 07:00 ET

AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 15, 2013, 13:37 ET

Noted Atherosclerosis Researcher Joins AtheroNova Team

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 11, 2013, 07:00 ET

AtheroNova Adds New Medical Advisor

 AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Mar 14, 2013, 18:18 ET

AtheroNova Announces Shareholder Realignment

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jan 17, 2013, 07:00 ET

AtheroNova to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Jan 08, 2013, 08:00 ET

AtheroNova Names New Clinical Affairs Officer

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Dec 18, 2012, 08:00 ET

AtheroNova Names New Chief Medical Officer

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Nov 15, 2012, 07:22 ET

AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic...

Nov 13, 2012, 08:00 ET

AtheroNova Announces Milestone Filing of IND in Russian Federation

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Nov 07, 2012, 08:22 ET

AtheroNova Names New Director

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 11, 2012, 09:26 ET

AtheroNova Completes $2.9 Million Private Placement of Common Stock

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Oct 09, 2012, 08:49 ET

Additional Study to Commence at The David Geffen School of Medicine at the University of California Los Angeles (UCLA)

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Sep 25, 2012, 08:34 ET

AtheroNova to Present at the 2012 Aegis Healthcare Conference in Las Vegas

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Sep 05, 2012, 09:00 ET

AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge